Drug-coated stent for the treatment of coronary artery disease
Vietnam·Risk Class TTBYT Loại D·Theo theo phụ lục·Theo theo phụ lục·Registered Sep 26, 2023- Analysis ID
- 2301008ĐKLH/BYT-HTTB
- Submission ID
- 18007275/ĐKLH-BYT-TB-CT
- Product Type
- Theo theo phụ lục
- Product Code
- Theo phụ lục
- Manufacturer
- Theo theo phụ lục
- Manufacturer Country
- Theo theo phụ lục
- Intended Use
- • New injuries (mainly in cases of stenosis or occlusion of the organ), including small blood vessels (Small Vessel Disease (SVD)) • Restenosis after percutaneous transluminal coronary angioplasty (PTCA) with balloon or stent (ISR) • Before and after balloon angioplasty in the stent implantation process • Acute or high-risk acute ischemic stroke
- Registration Date
- Sep 26, 2023
Companies providing products similar to "Drug-coated stent for the treatment of coronary artery disease"
Recently registered similar products
Access comprehensive regulatory information for Drug-coated stent for the treatment of coronary artery disease in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2301008ĐKLH/BYT-HTTB and manufactured by Theo theo phụ lục.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Hemoteq AG, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.